Recognify Life Sciences is a biotech company leveraging a Phase 2 ready asset to treat Cognitive Impairment associated with Schizophrenia (CIAS)
Recognify Life Sciences is a biotech company leveraging a Phase 2 ready asset to treat Cognitive Impairment associated with Schizophrenia (CIAS).